−1.20SEK
−116.07 MSEK
546.00 KSEK
79.52 M
About DIAMYD MEDICAL AB SER. B
Sector
CEO
Ulf Hannelius
Headquarters
Stockholm
Website
Employees (FY)
25
Founded
1984
ISIN
SE0021921467
FIGI
BBG01M2JYXB4
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. It also develops and invests in stem cell and medical technology. The company was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DMYD_BTU_B is 13.95 SEK — it has increased by 6.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange DIAMYD MEDICAL AB BTU B stocks are traded under the ticker DMYD_BTU_B.
Yes, you can track DIAMYD MEDICAL AB BTU B financials in yearly and quarterly reports right on TradingView.
DMYD_BTU_B stock has risen by 20.26% compared to the previous week, the month change is a 70.54% rise, over the last year DIAMYD MEDICAL AB BTU B has showed a 277.03% increase.
DMYD_BTU_B net income for the last quarter is −29.25 M SEK, while the quarter before that showed −32.78 M SEK of net income which accounts for 10.77% change. Track more DIAMYD MEDICAL AB BTU B financial stats to get the full picture.
Today DIAMYD MEDICAL AB BTU B has the market capitalization of 1.01 B, it has decreased by 10.94% over the last week.
No, DMYD_BTU_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DMYD_BTU_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIAMYD MEDICAL AB BTU B stock right from TradingView charts — choose your broker and connect to your account.
As of May 2, 2024, the company has 25.00 employees. See our rating of the largest employees — is DIAMYD MEDICAL AB BTU B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIAMYD MEDICAL AB BTU B EBITDA is −116.20 M SEK, and current EBITDA margin is −20.64 K%. See more stats in DIAMYD MEDICAL AB BTU B financial statements.